SQ-standardized house dust mite immunotherapy as an immunomodulatory treatment in patients with asthma
G. Blumberga, L. Groes and R. Dahl
Allergy Volume 66, Issue 2, pages 178–185, February 2011
Regulatory aspects of specific immunotherapy in Europe
Kaul S; Englert L; May S; Vieths S. Current Opinion in Allergy & Clinical Immunology: December 2010 – Volume 10 – Issue 6 – p 594–602
The Consolidated Standards of Reporting Trials (CONSORT) Statement applied to allergen-specific immunotherapy with inhalant allergens: A Global Allergy and Asthma European Network (GA2LEN) article
P. J. Bousquet, M.A. Calderón, P.Demoly, D. Larenas, G. Passalacqua, C. Bachert, J. Brozek, G.W. Canonica, T. Casale, J. Fonseca, R. Dahl, S.R. Durham, H. Merk, M. Worm, U. Wahn, T. Zuberbier, H.J. Schünemann, J. Bousquet. Journal of Allergy and Clinical Immunology. Volume 127, Issue 1 , Pages 49-56.e11, January 2011.
Regulatory environment for allergen-specific immunotherapy
S. Kaul, S. May, D. Lüttkopf and S. Vieths. Allergy Vol. 66 Issue 3. Published online: 3 FEB 2011
Registration trials for specific immunotherapy in Europe: advanced guidance from the new European Medical Agency guideline
V. Gödicke and F. Hundt. Allergy Volume 65, Issue 12, pages 1499–1505, December 2010
Specific immunotherapy by the sublingual route for respiratory allergy
Cristoforo Incorvaia, Simonetta Masieri, Patrizia Berto, Silvia Scurati and Franco Frati
Allergy, Asthma & Clinical Immunology 2010, 6:29
Epicutaneous/transcutaneous allergen-specific immunotherapy: rationale and clinical trials
Senti, Gabriela; Freiburghaus, Andreas U; Kundig, Thomas M
Current Opinion in Allergy and Clinical Immunology: December 2010 – Volume 10 – Issue 6 – p 582–586
